Xtant Medical Holdings Net Income
| XTNT Stock | USD 0.62 0.02 3.33% |
As of the 10th of February, Xtant Medical maintains the Mean Deviation of 2.86, market risk adjusted performance of 0.745, and Standard Deviation of 3.72. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xtant Medical Holdings, as well as the relationship between them.
Xtant Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.7954 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -14.8 M | -15.5 M | |
| Net Loss | -18.9 M | -19.9 M | |
| Net Loss | -9.8 M | -10.2 M | |
| Net Loss | (0.11) | (0.12) | |
| Net Income Per E B T | 1.16 | 0.72 |
Xtant | Net Income | Build AI portfolio with Xtant Stock |
The evolution of Net Income for Xtant Medical Holdings provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Xtant Medical compares to historical norms and industry peers.
Latest Xtant Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Xtant Medical Holdings over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Xtant Medical Holdings financial statement analysis. It represents the amount of money remaining after all of Xtant Medical Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Xtant Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (16.45 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Xtant Net Income Regression Statistics
| Arithmetic Mean | (14,872,399) | |
| Geometric Mean | 6,357,667 | |
| Coefficient Of Variation | (125.45) | |
| Mean Deviation | 11,721,779 | |
| Median | (8,485,000) | |
| Standard Deviation | 18,657,467 | |
| Sample Variance | 348.1T | |
| Range | 70.8M | |
| R-Value | (0.08) | |
| Mean Square Error | 368.8T | |
| R-Squared | 0.01 | |
| Significance | 0.76 | |
| Slope | (302,101) | |
| Total Sum of Squares | 5569.6T |
Xtant Net Income History
Other Fundumenentals of Xtant Medical Holdings
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Xtant Medical Net Income component correlations
Xtant Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Xtant Medical is extremely important. It helps to project a fair market value of Xtant Stock properly, considering its historical fundamentals such as Net Income. Since Xtant Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Xtant Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Xtant Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Xtant introduce new products? Factors like these will boost the valuation of Xtant Medical. Anticipated expansion of Xtant directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.19 | Return On Assets | Return On Equity |
Understanding Xtant Medical Holdings requires distinguishing between market price and book value, where the latter reflects Xtant's accounting equity. The concept of intrinsic value - what Xtant Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Xtant Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Xtant Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Xtant Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Xtant Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Xtant Medical.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Xtant Medical on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Xtant Medical Holdings or generate 0.0% return on investment in Xtant Medical over 90 days. Xtant Medical is related to or competes with Apyx Medical, Quipt Home, Avita Medical, Vivani Medical, InspireMD, Rapid Micro, and Lucid Diagnostics. Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for ... More
Xtant Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Xtant Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Xtant Medical Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 19.92 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 5.41 |
Xtant Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xtant Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Xtant Medical's standard deviation. In reality, there are many statistical measures that can use Xtant Medical historical prices to predict the future Xtant Medical's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | 0.735 |
Xtant Medical February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 0.745 | |||
| Mean Deviation | 2.86 | |||
| Coefficient Of Variation | (1,169) | |||
| Standard Deviation | 3.72 | |||
| Variance | 13.85 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | 0.735 | |||
| Maximum Drawdown | 19.92 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 5.41 | |||
| Skewness | 0.8974 | |||
| Kurtosis | 2.59 |
Xtant Medical Holdings Backtested Returns
Xtant Medical Holdings shows Sharpe Ratio of -0.0469, which attests that the company had a -0.0469 % return per unit of risk over the last 3 months. Xtant Medical Holdings exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Xtant Medical's Standard Deviation of 3.72, mean deviation of 2.86, and Market Risk Adjusted Performance of 0.745 to validate the risk estimate we provide. The firm maintains a market beta of -0.45, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Xtant Medical are expected to decrease at a much lower rate. During the bear market, Xtant Medical is likely to outperform the market. At this point, Xtant Medical Holdings has a negative expected return of -0.18%. Please make sure to check out Xtant Medical's mean deviation, total risk alpha, as well as the relationship between the Total Risk Alpha and daily balance of power , to decide if Xtant Medical Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.49 |
Modest reverse predictability
Xtant Medical Holdings has modest reverse predictability. Overlapping area represents the amount of predictability between Xtant Medical time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Xtant Medical Holdings price movement. The serial correlation of -0.49 indicates that about 49.0% of current Xtant Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.49 | |
| Spearman Rank Test | -0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Xtant Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Xtant Medical Holdings reported net income of (16.45 Million). This is 104.82% lower than that of the Health Care Equipment & Supplies sector and 106.91% lower than that of the Health Care industry. The net income for all United States stocks is 102.88% higher than that of the company.
Xtant Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xtant Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xtant Medical could also be used in its relative valuation, which is a method of valuing Xtant Medical by comparing valuation metrics of similar companies.Xtant Medical is currently under evaluation in net income category among its peers.
Xtant Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Xtant Medical from analyzing Xtant Medical's financial statements. These drivers represent accounts that assess Xtant Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Xtant Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 47.9M | 62.1M | 134.6M | 59.2M | 53.3M | 37.7M | |
| Enterprise Value | 46.5M | 58.9M | 152.4M | 88.2M | 101.4M | 106.7M |
Xtant Fundamentals
| Return On Equity | 0.0364 | ||||
| Return On Asset | 0.0387 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 105.85 M | ||||
| Shares Outstanding | 140 M | ||||
| Shares Owned By Insiders | 16.45 % | ||||
| Shares Owned By Institutions | 57.10 % | ||||
| Number Of Shares Shorted | 24.74 K | ||||
| Price To Earning | (0.41) X | ||||
| Price To Book | 1.66 X | ||||
| Price To Sales | 0.63 X | ||||
| Revenue | 117.27 M | ||||
| Gross Profit | 82.54 M | ||||
| EBITDA | (7.88 M) | ||||
| Net Income | (16.45 M) | ||||
| Cash And Equivalents | 16.5 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 35.14 M | ||||
| Debt To Equity | 0.60 % | ||||
| Current Ratio | 3.57 X | ||||
| Book Value Per Share | 0.36 X | ||||
| Cash Flow From Operations | (11.9 M) | ||||
| Short Ratio | 0.11 X | ||||
| Earnings Per Share | 0.01 X | ||||
| Price To Earnings To Growth | (0.03) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 217 | ||||
| Beta | -0.31 | ||||
| Market Capitalization | 83.76 M | ||||
| Total Asset | 93.84 M | ||||
| Retained Earnings | (259.46 M) | ||||
| Working Capital | 38.53 M | ||||
| Current Asset | 45.04 M | ||||
| Current Liabilities | 21.47 M | ||||
| Net Asset | 93.84 M |
About Xtant Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xtant Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xtant Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xtant Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xtant Stock Analysis
When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.